Sign in
Discontinuation of Quetiapine From an NIMH-Funded Trial Due to Serious Adverse Events
Letter/Communication

Discontinuation of Quetiapine From an NIMH-Funded Trial Due to Serious Adverse Events

DILIP V. Jeste, HUA Jin, SHAHROKH Golshan, SUNDER Mudaliar, DANIELLE Glorioso, IAN Fellows, HELENA Kraemer and STEPHAN Arndt
The American journal of psychiatry, Vol.166(8), pp.937-938
08/01/2009
DOI: 10.1176/appi.ajp.2009.09040501
PMID: 19651757

View Online

Details

Metrics

1 Record Views
Logo image